In vitro drug absorption enhancement effects of aloe vera and aloe ferox

Scientia Pharmaceutica

Volumn 80, Issue 2, 2012, Pages 475-486

  Beneke, Catharina ^a   Viljoen, Alvaro ^a   Hamman, Josias ^a,b  

^a TSHWANE UNIVERSITY OF TECHNOLOGY   (South Africa)

^b NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Aloe ferox; Aloe vera; Drug absorption enhancement; In vitro transport; Transepithelial electrical resistance

Indexed keywords

ATENOLOL; DALTONMAX 700; PLANT MEDICINAL PRODUCT; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ALOE; ALOE FEROX; ALOE VERA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; GEL; IN VITRO STUDY; INTESTINE; INTESTINE EPITHELIUM CELL; NONHUMAN; PLANT LEAF; PRECIPITATION; RAT; STATISTICAL SIGNIFICANCE; TIGHT JUNCTION;

EID: 84865149967     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1202-10     Document Type: Article

References (21)

1. Gomez-Orellana I. Strategies to improve oral drug bioavailability. Expert Opin Drug Deliv. 2005; 2: 419-433. http://dx.doi.org/10.1517/17425247.2.3.419
2. Whitehead K, Karr N, Mitragotri S. Safe and effective permeation enhancers for oral drug delivery. Pharm Res. 2008; 25: 1782-1788. http://dx.doi.org/10.1007/s11095-007-9488-9
3. Sharma P, Varma MVS, Chawla HPS, Panchagnula R. Relationship between lipophilicity of BCS class III and IV drugs and the functional activity of peroral absorption enhancers. Il Farmaco. 2005; 60: 870-873. http://dx.doi.org/10.1016/j.farmac.2005.08.006
4. Thanou M, Verhoef JC, Junginger HE. Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Del Rev. 2001; 52: 117-126. http://dx.doi.org/10.1016/S0169-409X(01)00231-9
5. Boudreau MD, Beland FA. An evaluation of the biological and toxicological properties of Aloe barbadensis (Miller), Aloe vera. J Environ Sci Health C. 2006; 24: 103-154. http://dx.doi.org/10.1080/10590500600614303
6. Bozzi A, Perrin C, Austin S, Vera FA. Quality and authenticity of commercial aloe vera gel powders. Food Chem. 2007; 103: 22-30. http://dx.doi.org/10.1016/j.foodchem.2006.05.061
7. Rosca-Casian O, Parvu M, Vlase L, Tamas M. Antifungal activity of Aloe vera leaves. Fitoterapia. 2007; 78: 219-222. http://dx.doi.org/10.1016/j.fitote.2006.11.008
8. Zhang L, Tizard IR. Activation of a mouse macrophage cell line by acemannan: The major carbohydrate fraction from Aloe vera gel. Immunopharmacology. 1996; 35: 119-128. http://dx.doi.org/10.1016/S0162-3109(96)00135-X
9. Pugh N, Ross SA, ElSohly MA, Pasco DS. Characterization of aloeride, a new high-molecular-weight polysaccharide from Aloe vera with potent immunostimulatory activity. J Agric Food Chem. 2001; 49: 1030-1034. http://dx.doi.org/10.1021/jf001036d
10. Jia J, Dong C, Zhang W, Cui Y, Liu J. Evaluation of pharmacokinetic and pharmacodynamic relationship for oral sustained-release atenolol pellets in rats. J Pharm Biomed Anal. 2011; 55: 342-348. http://dx.doi.org/10.1016/j.jpba.2011.01.044
11. Lu E-X, Jiang Z-Q, Zhang Q-Z, Jiang X-G. A water-insoluble drug monolithic osmotic tablet system utilizing gum arabic as an osmotic, suspending and expanding agent. J Control Release. 2003; 92: 375-382. http://dx.doi.org/10.1016/S0168-3659(03)00371-7
12. Im S-A, Oh S-T, Song S, Kim M-R, Kim D-S, Woo S-S, Jo TH, Park YI, Lee C-K. Identification of optimal molecular size of modified Aloe polysaccharides with maximum immunomodulatory activity. Int Immunopharmacol. 2005; 5: 271-279. http://dx.doi.org/10.1016/j.intimp.2004.09.031
13. Shackleton CM, Gambiza J. Growth of Aloe ferox Mill. at selected sites in the Makana region of the Eastern Cape. S Afr J Bot. 2007; 73: 266-269. http://dx.doi.org/10.1016/j.sajb.2006.12.003
14. O'Brien C, Van Wyk BE, Van Heerden FR. Physical and chemical characteristics of Aloe ferox leaf gel. S Afr J Bot. 2011; 77: 988-995. http://dx.doi.org/10.1016/j.sajb.2011.08.004
15. Vinson JA, Al Kharrat H, Andreoli L. Effect of Aloe vera preparations on the human bioavailability of vitamins C and E. Phytomedicine. 2005; 12: 760-765. http://dx.doi.org/10.1016/S0169-409X(01)00231-9
16. Chen W, Lu Z, Viljoen A, Hamman J. Intestinal drug transport enhancement by Aloe vera. Planta Med. 2009; 75: 587-595. http://dx.doi.org/10.1055/s-0029-1185341
17. Schipper NGM, Vårum KM, Stenberg P, Ocklind G, Lennernäs H, Artursson P. Chitosans as absorption enhancers of poorly absorbable drugs: 3: Influence of mucus on absorption enhancement. Eur J Pharm Sci. 1999; 8: 335-343. http://dx.doi.org/10.1016/S0928-0987(99)00032-9
18. Johnson PH, Frank D, Costantino HR. Discovery of tight junction modulators: significance for drug development and delivery. Drug Discov Today. 2008; 13: 261-267. http://dx.doi.org/10.1016/j.drudis.2007.10.023
19. Kotzé AF, LueBen HL, de Leeuw BJ, de Boer BG, Verhoef CJ, Junginger HE. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J Control Release. 1998; 51: 35-46. http://dx.doi.org/10.1016/S0168-3659(97)00154-5
20. Hamman JH, Schultz CM, Kotzé AF. N-trimethyl chitosan chloride: optimum degree of quaternization for drug absorption enhancement across epithelial cells. Drug Dev Ind Pharm. 2003; 29: 161-172. http://dx.doi.org/10.1081/DDC-120016724
21. Whitehead K, Karr N, Mitragoth S. Safe and effective permeation enhancers for oral drug delivery. Pharm Res. 2008; 25: 1782-1788. http://dx.doi.org/10.1016/S0169-409X(01)00231-9